CORVISION Trademark

Trademark Overview


On Friday, January 31, 2020, a trademark application was filed for CORVISION with the United States Patent and Trademark Office. The USPTO has given the CORVISION trademark a serial number of 79286492. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by LinkoCare Life Sciences AB. The CORVISION trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Collagen for medical use; biological implants, namely, biological eye tissue intended for subsequent implantation, biological skin tissue intended for subsequent implantation, biological cardiac tissue intended for subsequent implantation, biological tissue grafts; biological corneal, cardiac, nerve, and skin tissue for implantation; surgical implants comprised of living tissues; biological materials in the nature of biological preparation for the treatment of eye disease for medical purposes; bioengineered materials in the nature of biological eye tissue; bioengineered biological organ tissues for medical, veterinary and pharmaceutical purposes; biological implants comprising biopolymers, namely, collagen, nanocellulose, and living tissue for delivery of stem cells and biological agents; implants comprising living tissue; implants comprising biopolymers, namely, collagen, nanocellulose for guided tissue regeneration; surgical implants biopolymers, namely, collagen, nanocellulose and n...

Corneal implants in the form of inlays made of artificial and natural, non-living, materials; corneal microlens for sight correction being implants made of artificial and natural, non-living, materials; corneal shields being surgical implants and contact lenses made of artificial and natural, non-living, materials; corneal implants made of artificial and natural, non-living, materials; corneal implants for sight correction made of artificial and natural, non-living, materials; intra-corneal implants made of artificial and natural, non-living, materials; intra-ocular implants made of artificial and natural, non-living, materials; ocular implants made of artificial and natural, non-living, materials; medical implants made of artificial and natural, non-living, materials; biodegradable implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; prosthetic implants for eye, skin, and heart applications, made of artificial and natural, non-living, ...
corvision

General Information


Serial Number79286492
Word MarkCORVISION
Filing DateFriday, January 31, 2020
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6495490
Registration DateTuesday, September 28, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements


Goods and ServicesCollagen for medical use; biological implants, namely, biological eye tissue intended for subsequent implantation, biological skin tissue intended for subsequent implantation, biological cardiac tissue intended for subsequent implantation, biological tissue grafts; biological corneal, cardiac, nerve, and skin tissue for implantation; surgical implants comprised of living tissues; biological materials in the nature of biological preparation for the treatment of eye disease for medical purposes; bioengineered materials in the nature of biological eye tissue; bioengineered biological organ tissues for medical, veterinary and pharmaceutical purposes; biological implants comprising biopolymers, namely, collagen, nanocellulose, and living tissue for delivery of stem cells and biological agents; implants comprising living tissue; implants comprising biopolymers, namely, collagen, nanocellulose for guided tissue regeneration; surgical implants biopolymers, namely, collagen, nanocellulose and native tissue, grown from stem cells; implantable materials in the nature of biopolymers, namely, collagen, nanocellulose, and native tissue for use in guided tissue regeneration; cell culture media for medical purposes for cultivating human and animal cells such as corneal, and cardiac cells and stem cells
Goods and ServicesCorneal implants in the form of inlays made of artificial and natural, non-living, materials; corneal microlens for sight correction being implants made of artificial and natural, non-living, materials; corneal shields being surgical implants and contact lenses made of artificial and natural, non-living, materials; corneal implants made of artificial and natural, non-living, materials; corneal implants for sight correction made of artificial and natural, non-living, materials; intra-corneal implants made of artificial and natural, non-living, materials; intra-ocular implants made of artificial and natural, non-living, materials; ocular implants made of artificial and natural, non-living, materials; medical implants made of artificial and natural, non-living, materials; biodegradable implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; prosthetic implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; artificial implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials for delivery of cells, stem cells, drugs, genes, and proteins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 29, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLinkoCare Life Sciences AB
Party Type30 - Original Registrant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameLinkoCare Life Sciences AB
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameLinkoCare Life Sciences AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Trademark Events


Event DateEvent Description
Thursday, May 28, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 29, 2020ASSIGNED TO EXAMINER
Tuesday, June 2, 2020APPLICATION FILING RECEIPT MAILED
Monday, June 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 9, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 14, 2020REFUSAL PROCESSED BY MPU
Tuesday, July 14, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 1, 2020REFUSAL PROCESSED BY IB
Friday, December 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, December 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 9, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 18, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, December 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, January 9, 2021FINAL REFUSAL WRITTEN
Saturday, January 9, 2021FINAL REFUSAL E-MAILED
Friday, June 4, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 23, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 4, 2021EXAMINERS AMENDMENT E-MAILED
Friday, June 4, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 4, 2021EXAMINER'S AMENDMENT ENTERED
Friday, June 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 23, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sunday, July 11, 2021NOTIFICATION PROCESSED BY IB
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Friday, March 7, 2025NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 4, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 14, 2022FINAL DISPOSITION PROCESSED
Tuesday, March 15, 2022FINAL DISPOSITION NOTICE SENT TO IB